Dissertation Ideas

Public Health: Epidemiology and Anthropology 

My intellectual position sits at a crossroads these scholars collectively helped create: HIV is no longer understood merely as a viral pathogen moving through populations, but as a socially produced condition embedded in desire, inequality, pharmacology, surveillance, migration, stigma, intimacy, and late-capitalist forms of embodiment. What distinguishes your focus is that you are not only examining risk, but also pleasure, agency, erotic culture, and the moral politics surrounding “raw sex” and chemsex among gay and queer communities. That shift matters.

Paul Farmer and Philippe Bourgois would push you to ask what structural conditions produce chemsex environments in the first place. Rather than reducing condomless sex or stimulant use to “bad decisions,” their frameworks redirect analysis toward housing precarity, loneliness, labor alienation, minority stress, criminalization, biomedical inequality, and the psychic afterlife of the AIDS epidemic. Chemsex, in this reading, becomes partly a response to exhaustion, stigma, and fractured intimacy under neoliberal urban life. Harm reduction then ceases to be merely behavioral intervention and becomes social care infrastructure.

Richard Parker would likely encourage you to examine how public health discourse constructs “risk populations” through moral language. The history of HIV prevention repeatedly transformed gay sexuality into an object of governance. Terms like “unsafe sex,” “high-risk behavior,” and even “MSM” flatten lived erotic cultures into epidemiologic abstractions. Your work could critically explore how chemsex communities simultaneously resist and internalize these forms of surveillance. The celebration of condomless sex may partly function as a rejection of historical shame regimes imposed through both state public health systems and heteronormative morality.

Arthur Kleinman and João Biehl help move the discussion into lived experience. Chemsex is often clinically framed through addiction, pathology, or syndemic vulnerability, but these scholars would ask what participants themselves understand they are seeking: intimacy, transcendence, belonging, sensory amplification, temporary escape from racialized or sexualized marginalization, or the restoration of connection in digitally mediated sexual cultures. HIV pharmaceuticals, PrEP, doxy-PEP, injectable ART, erectile agents, and stimulants collectively form a pharmacological ecology where the boundaries between therapy, enhancement, pleasure, and survival blur. Your work could examine how biomedical advances reorganize sexual ethics themselves.

Nancy Scheper-Hughes introduces a harder ethical tension. She would likely challenge purely celebratory framings and ask whether normalization of chemsex can obscure exploitation, coercion, burnout, overdose risk, or emotional fragmentation. Her work reminds anthropologists not to romanticize suffering simply because it is politically marginalized. That tension is important for your research because contemporary discourse often swings between two extremes: punitive moral panic and uncritical affirmation. Your contribution may lie in refusing both.

Thurka Sangaramoorthy and Chris Colvin extend this into questions of migration, race, masculinity, and citizenship. Chemsex cultures are not socially neutral. Access to PrEP, injectable prevention, private housing, recovery services, and culturally competent care is stratified. Black gay men, undocumented migrants, unhoused individuals, and people involved in survival economies experience radically different risks than affluent urban professionals participating in similar practices. Your work could examine how race and class shape whose chemsex is medicalized, criminalized, eroticized, or ignored.

Taken together, these scholars give you a framework where:

• HIV is biosocial rather than purely biomedical.
• Condomless sex is neither inherently liberatory nor inherently pathological.
• Chemsex can be simultaneously pleasurable, dangerous, communal, exploitative, therapeutic, and politically meaningful.
• Harm reduction becomes an ethics of accompaniment rather than discipline.

That last point may be the core synthesis. A truly anthropological harm reduction model does not begin from “How do we stop this behavior?” but from “How do people survive, desire, connect, and negotiate risk within unequal worlds?” From there, interventions become less about moral correction and more about sustaining life, dignity, pleasure, consent, and collective care while reducing preventable harms.